Cargando...

Pembrolizumab-Induced Mobitz Type 2 Second-Degree Atrioventricular Block

Pembrolizumab is a monoclonal antibody directed towards programmed cell death protein 1 (PD-1) and is an antineoplastic drug which has a growing variety of oncologic uses. Pembrolizumab is commonly associated with immune-related adverse events (IRAEs) but is infrequently noted to cause cardiotoxicit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Case Rep Cardiol
Autores principales: Khan, Alisha, Riaz, Sana, Carhart, Robert
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007942/
https://ncbi.nlm.nih.gov/pubmed/32047674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8428210
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!